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Abstract
Introduction: Dyslipidemia is an established risk 
factor for atherosclerosis and cardiovascular disease. 
It is common among children undergoing maintenance 
dialysis. To our knowledge, this is the first report on 
the lipid profile of children undergoing maintenance 
hemodialysis (HD) or continuous ambulatory peritoneal 
dialysis (CAPD) in Sudan. 
Methods: We studied 17 children on HD, 11 children on 
CAPD and 28 controls. The levels of total cholesterol 
(TC), triglycerides (TGD) and high density lipoprotein 
cholesterol (HDL-C) were measured from fasting serum 
samples using electrophoresis and low density lipoprotein 
cholesterol (LDL-C) was then calculated. 
Results: End stage renal failure (ESRF) children had 
higher mean TC (193±36 versus 135±17 mg/dl), higher 
mean TGD (120±38 versus 90±15 mg/dl), higher mean 
LDL-C (129±32 versus 69±18 mg/dl), and lower mean 
HDL-C (39±12 versus 49±4 mg/dl) than controls (P=0.00 
for all parameters). CAPD patients had higher mean 
TC (211±39 versus 181±30 mg/dl) and higher LDL-C 
(145±35 versus 118±25 mg/dl) than controls (P=0.03 for 
both parameters). The prevalence of dyslipidemia among 
ESRF patients was 75% while none of the control group 
had lipid parameters outside the accepted range. Among 
ESRF patients, 39.3% had TC > 200 mg/dl, 21.4% had 
TGD > 150 mg/dl, 42.9% had LDL-C > 130 mg/dl, and 
35.7% had HDL-C < 35 mg/dl. Abnormal HDL-C values 
were more prevalent among CAPD patients compared to 
HD patients (52.9% versus 9.1%, P=0.02)
Conclusion: Despite the small number of studied 
children, this study is likely to reflect the high prevalence 
of dyslipidemia among children undergoing maintenance 
dialysis treatment in Sudan. 
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Introduction
Improvement in dialysis adequacy has increased the 
survival of pediatric patients on maintenance dialysis. With 
increasing numbers of long-term survivors undergoing such 
treatment, complications like dyslipidemia are becoming 
more frequent. Dyslipidemias are disorders of lipoprotein 
metabolism that result in excess total cholesterol (TC), 
excess low-density lipoprotein cholesterol (LDL-C), 
excess triglyceride (TGD), or deficiency of high-density 
lipoprotein cholesterol (HDL-C). Dyslipidemia patterns 
similar to familial hypertriglyceridemia or type IV 
hyperlipidemia were found to be common in pediatric 
patients undergoing chronic dialysis treatment [1-4]. 
There are many factors which may contribute to the 
risk of dyslipidemia in chronic dialysis patients, such 
as a diet rich in fat and carbohydrates [1], medications 
[5], use of high molecular weight heparin [6], decrease 
in lipoprotein lipase level [1], high glucose content of 
dialysate [7] and L-carnitine deficiency [1]. This early 
onset of childhood dyslipidemia together with prolonged 
survival of ESRF children having adequate dialysis, 
may subject these patients to high risk of complications 
including premature coronary artery disease [1, 8-10]. 
Moreover, such dyslipidemia may persist even after 
successful renal transplantation [11]. 
Although conclusive data regarding the risks and the 
benefits of treatment of dyslipidemia are lacking, 
early detection, prevention and probably treatment are 
recommended in this population of children. There is 
no study to date to show the effect of chronic dialysis 
on the lipid profile of pediatric ESRF patients in Sudan. 
The aim of this study was to determine the lipid profile 
of a group of Sudanese end stage renal failure (ESRF) 
pediatric patients maintained on hemodialysis (HD) or 
continuous ambulatory peritoneal dialysis (CAPD) in 
comparison to a control group.
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Methods
A total of 56 children (28 ESRF patients and 28 controls) 
were enrolled in the study. Data were collected between 
December 2006 and May 2007. ESRF patients were 
recruited from two renal centers in Khartoum, Sudan; 
the first center is a specialized pediatric renal center 
based in Soba University Hospital while the other is an 
independent renal unit that cares for adult and pediatric 
ESRF patients and lacks a pediatric nephrologist. The 
ESRF group included 17 patients on maintenance HD 
and 11 patients on CAPD, all of whom were on treatment 
for at least 3 months. CAPD patients were managed in 
adherence to the International Society of Peritoneal 
Dialysis (ISPD) guide-lines [12]. HD patients were 
dialysed using appropriate-size dialysers and received 
three four-hourly sessions of HD per week. Informed 
consent was obtained from children’s parents. Data 
pertaining to age, gender, duration of dialysis and body 
mass index z-score (BMI z-score) was collected. After 
10-hours overnight fasting, heparinized venous blood 
samples were collected. The overnight fast imposed no 
severe restrictions on the children because most of our 
children do not have meals between 9-10 pm and 7-8 am. 
The levels of TC, TGD and HDL-C were measured using 
electrophoresis. Very low density lipoprotein cholesterol 
(VLDL-C) levels were calculated using the equation:
VLDL-C = TGD/5
LDL-C was then calculated using the equation:
LDL-C= TC – (HDL-C + VLDL-C) [13]
The National Cholesterol Education Program (NCEP) 
report recommends using the same cut points to identify 
children and adolescents with abnormal lipid and 
lipoprotein concentrations, from 2 to 18 years of age [14]. 
For the purpose of this study, dyslipidemia was defined 
by TC levels > 200 mg/dl, LDL-C levels > 130 mg/dl, 
TGD levels > 150 mg/dl or HDL-C levels < 35 mg/dl in 
accordance with the NCEP group [14] and the American 
Heart Association guidelines [15].
Data was analysed using Statistical Package for Social 
Sciences (SPSS) version 11.5. Lipid profiles of the two 
groups were expressed as mean ± SD and compared using 
Student’s t-test. Chi-squared test was used to examine the 
association between dyslipidemia and different clinical 
parameters. P value less than 0.05 was considered as 
significant.
Results
The study included 28 ESRF patients. The cause of 
renal failure was obstructive uropathy in eight children 
(28.5%), glomerulonephritis in three children (10.7), 
metabolic disorders in two children (7.2%), sickle cell 
nephropathy in one child (3.6%), and unknown in the 
remainder. Demographic and clinical characteristics of 
studied children are shown (Table 1). Children in the 
ESRF group were older, more commonly females and 
had lower BMI compared to the control group, but there 
Table 1:  Demographic and clinical characteristics of studied children
Characteristics Controls (28) HD (17) CAPD (11)
Age in years (mean ± SD) 9 ± 1.9 12.7 ± 3.8 10.3 ± 4.5
Age range 6 - 12 4 - 17 4 - 17
Male gender (%) 35.7 70.6 63.6
BMI age centile (mean ± SD) 56.9 ± 26.9 11.8 ± 21.9 15.5 ± 18.9
BMI Z-score (mean ± SD) 0.2 ± 0.8 - 2.9 ± 2.7 - 3.3 ± 3.6
Dialysis duration in months (mean ± SD) - 14.8 ± 18.5 7.2 ± 7.7
Table 2: Comparison of lipid parameters between ESRF patients and controls (mean ± SD)
Lipid parameter Control ESRF P value
TC 135.2 ± 17.3 192.8 ± 36.2 0.00 *
TGD 90.2 ± 14.9 120 ± 38 0.00 *
LDL-C 68.8 ± 17.6 128.8 ± 31.6 0.00 *
HDL-C 49.1 ± 3.5 39.4 ± 11.5 0.00 *
* Statistically significant
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were no significant differences between HD and CAPD 
patients.
ESRF patients had significantly higher TC, TGD, LDL-C 
and lower HDL-C values compared to controls (Table 2). 
CAPD patients had significantly higher TC and LDL-C 
values compared to HD patients (Table 3). 
Age, gender and BMI z-score were not correlated to lipid 
profile values in the control group. Gender, BMI z-score 
and dialysis duration had no correlation to lipid profile 
in the ESRF group. Age had a weak negative correlation 
with HDL-C (R = - 0.43, P < 0.05) in the ESRF group, 
but was not correlated to other lipid parameters.
The prevalence of dyslipidemia among ESRF patients 
was 75% while none of the control group had lipid 
parameters outside the accepted range. Among ESRF 
patients, 39.3% had TC > 200 mg/dl, 21.4% had TGD > 
150 mg/dl, 42.9% had LDL-C > 130 mg/dl, and 35.7% 
had HDL-C < 35 mg/dl. Abnormal HDL-C values were 
more prevalent among CAPD patients compared to HD 
patients, but the prevalence of other parameters was not 
significantly different between the two groups (Table 4)
Discussion
Evaluation of dyslipidemia in children is complicated 
by the known age, sexual, and ethnic differences in lipid 
concentrations. In the 1988–1994 National Health and 
Nutrition Examination Surveys (NHANES), age specific 
values for mean TC were found to peak at 9-11 years of 
age, subsequently decrease during pubertal development 
and then increase thereafter [16]. Females were found to 
have higher TC and LDL-C concentrations than males, 
and tended to have higher HDL-C concentrations than 
males after pubertal development [16]. In the same report, 
black children were found to have higher HDL-C and 
lower TGD concentrations than children of non-Hispanic 
white and Hispanic descent [16]. In the Cardiovascular 
Health in Children Study of 8-10 year-olds in North 
Carolina, 18.7% of black children had TC > 200 mg/dl 
compared with 11% of white children [17]. Compared to 
the reported values of American children and adolescents 
[16], our control group displayed lower mean TC (135 
mg/dl versus 160 mg/dl) and lower LDL-C (69 mg/dl 
versus 100 mg/dl). However, this small group may not 
accurately represent the local population.
Disturbances of lipid metabolism in children with chronic 
renal failure had been reviewed by Querfeld in 1993 [4]. 
He reported that uremic dyslipidemia characterised by 
high TGD and low HDL-C serum levels was present 
in the majority of patients whereas levels of TC, 
LDL-C and VLDL-C were frequently elevated. In this 
study, we found that this group of pediatric patients on 
maintenance dialysis have approximately similar pattern 
of dyslipidemia as described above. Similar observations 
have been made by many other investigators. Pennisi et 
al [10], Papadopoulou et al [18], and Asayama et al [19] 
have reported high levels of serum TGD in the majority 
of their children patients on maintenance HD (93%, 63% 
Table 3: Comparison of lipid parameters between patients undergoing HD and CAPD (mean ± SD)
Lipid parameter HD CAPD P value
TC 180.9 ± 29.7 211.2 ± 39.1 0.03 *
TGD 115 ± 30.3 127.8 ± 48.2 0.39 
LDL-C 118.4 ± 25.3 144.8 ± 34.8 0.03 *
HDL-C 37.5 ± 13.5 42.5 ± 6.7 0.27
* Statistically significant
Table 4: Prevalence of abnormalities in lipid parameters among ESRF patients (%)
Lipid parameter HD CAPD P value
TC > 200 mg/dl 35.3 45.5 0.4
TGD > 150 mg/dl 11.8 36.4 0.1
LDL-C > 130 mg/dl 35.3 54.5 0.3
HDL-C < 35 mg/dl 52.9 9.1 0.02 *
Dyslipidemia 76.5 72.7 0.6
* Statistically significant
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and 100% respectively). Significantly elevated levels 
of serum TC were reported in two of these studies [10, 
18]. Likewise, high serum levels of TC and TGD have 
been reported in pediatric patients undergoing peritoneal 
dialysis in many previous studies [3, 20-22]. Alterations 
in lipid profiles were often found to be more pronounced 
in PD patients than HD patients [22-25]. However, some 
studies observed no such difference in serum lipids on 
either type of dialysis treatments [20]. In this series we 
demonstrated significantly higher TC and LDL-C in 
CAPD compared to HD patients.
Conclusion 
Despite the small number of studied children, this study is 
likely to reflect the situation among children undergoing 
maintenance dialysis treatment in Sudan. Dyslipidemia 
was found to be very common in this group of ESRF 
patients. 
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